Form 4: Twist Bioscience SVP Sells Shares for Tax Obligations

Twist Bioscience SVP of Human Resources, Paula Green, sold 1,194 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

Summary

• Paula Green, SVP of Human Resources at Twist Bioscience Corp (TWST), reported a transaction involving company common stock.
• On February 3, 2026, Green disposed of 1,194 shares of common stock at a price of $46.576 per share.
• The sale was a 'sell to cover' transaction, mandated by the issuer's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units.
• This transaction does not represent a discretionary trade by the reporting person.
• Following the reported transaction, Paula Green beneficially owns 165,445 shares of Twist Bioscience common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transaction is a non-discretionary 'sell to cover' for tax purposes, which is a routine administrative action and does not reflect management's sentiment on the company's future prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The sale represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.
• These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions are a standard practice in equity compensation plans, allowing executives to meet tax liabilities arising from the vesting of restricted stock units without needing to use personal funds. This is a common and routine event across various industries for executives receiving equity-based compensation.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and not indicative of a change in management's investment thesis.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 filing details a routine 'sell to cover' transaction by an executive to satisfy tax obligations upon RSU vesting. Such non-discretionary sales are common and do not typically signal a change in the company's fundamentals or management's outlook. Therefore, a seasoned investor would likely maintain their current position, as this event alone does not provide new information warranting a 'buy' or 'sell' recommendation.

Keywords

Twist Bioscience, TWST, Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, Tax Withholding, Equity Compensation